Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by BILLMINERon Jan 09, 2017 11:18pm
204 Views
Post# 25686573

Sp speculation

Sp speculationAnyone care to speculate what  the sp will be if we receive the positive results we are hoping for from the first 3 or perhaps 6 patients? Im hoping to see it perhaps in the 1.50 range. I for one think the latest run up is in fact due to the Morningstar fair value report, and that we haven't even begun the treAtments yet on the first 3 patients. Ironic how we are at 37 cents and that's exactly what the fair value number was issued by Morningstar. I believe the interest level will increase dramatically over the next few months and thus higher trading volumes. I tend to take a more realistic approach to speculation of stocks and prices.  This trial is a foot in the door and a place for Theralase to start. I think they have the technology and down the road this company may have that multi billion market cap. I do hope I'm proved wrong and we see it explode by spring. All the best to the longs 
Bullboard Posts